Ancestry-informative markers are sets of polymorphisms for a particular DNA sequence that appear in substantially different frequencies between populations from different geographical regions of the world. Ancestry-informative markers can be used to estimate the geographical origins of the ancestors of an individual typically by continent of origin (Africa, Asia, or Europe).
To play the media you will need to either update your browser to a recent version or update your Flash plugin
Ancestry informative markers refers to locations in the genome that have varied sequences at that location and the relative abundance of those markers differs based on the continent from which individuals can trace their ancestry. So by using a series of these ancestry informative markers, sometimes 20 or 30 or more, and genotyping an individual you can determine from the frequency of those markers where their great, great, great, great ancestors may have come from. These are generally resolved to the three major continents: Africa, Asia, and Europe.
Ancestry informative markers are used in epidemiological studies to see whether or not people have the same background, and sometimes they are used in forensic studies as well.
Name: Lawrence C. Brody, Ph.D.
Occupation: Chief & Senior Investigator, Genome Technology Branch; Head, Molecular Pathogenesis Section
Biography: Dr. Brody investigates the genetics of breast cancer and neural tube defects. As chief of the NHGRI Genome Technology Branch's Molecular Pathogenesis section, he is interested in studying genetic mutations that lead to perturbations in normal metabolic pathways and cause disorders such as cancer and birth defects. His laboratory investigates mutations in two breast cancer-linked genes, breast cancer gene 1 (BRCA1) and breast cancer gene 2 (BRCA2). Dr. Brody's laboratory was among the first to report that women carrying BRCA1 or BRCA2 mutations have a higher risk of developing both breast and ovarian cancer than women without such mutations.